(Q41749102)

English

A strategy for evaluating lymphokine activation and novel monoclonal antibodies in antibody-dependent cell-mediated cytotoxicity and effector cell retargeting assays

scientific article published on January 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

A strategy for evaluating lymphokine activation and novel monoclonal antibodies in antibody-dependent cell-mediated cytotoxicity and effector cell retargeting assays (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

author name string

R P Junghans

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

publication date

1 January 1990

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

207-212

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

NIH conference. Immunomodulators in clinical medicine

1 reference

https://api.crossref.org/works/10.1007%2FBF01789170

21 January 2018

Antibody-dependent cell-mediated cytolysis (ADCC): analyses and projections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reassessment of LAK phenomenology: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of human natural killer cell activity by recombinant human interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interleukin 2 rapidly augments human natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation of normal human promyelocytes and myelocytes after a single pulse stimulation by purified GM-CSF or G-CSF.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting of cytotoxic cells with heterocrosslinked antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of resting human peripheral blood natural killer cells to interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of cells infected with HIV-1 by human lymphocytes targeted with monoclonal antibody heteroconjugates

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decay-accelerating factor (DAF): a review of its function and structure

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of human large granular lymphocytes and relationship to natural killer and K cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2379218

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01789170

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41749102&oldid=2204753969"